Evidence map›Paper›PMID 42483150›Full record

Trial reportDepression and anxiety2026

Reducing Public Stigma Toward Suicide-Loss Survivors Through Brief Video Interventions: A Randomized Controlled Trial.

Yossi Levi-Belz, Chana T Fisch, Amsalem Doron

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Depression and anxiety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yossi Levi-BelzThe Lior Tsfaty Center for Suicide and Mental Pain Studies, University of Haifa, Haifa, Israel, haifa.ac.il.ORCID https://orcid.org/0000-0002-8865-5639
Chana T FischNew York State Psychiatric Institute and Department of Psychiatry, New York, New York, USA.
Amsalem DoronNew York State Psychiatric Institute and Department of Psychiatry, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Suicide-loss survivors (SLSs) experience substantial and often enduring psychological burden. These difficulties are compounded by public stigma, underscoring the need for scalable approaches to shift attitudes at the population level. In this study, we examined whether brief survivor-narrative videos can reduce public stigma of SLSs. Methods: In a randomized controlled trial, 1351 adults (18-50) completed baseline measures and were allocated to view either a brief SLS narrative or a psychoeducational control. Public stigma toward SLSs and trait impressions were assessed at baseline and postexposure. Results: Relative to control, the SLS video arm showed clear improvements immediately and at 30 days: stigma scores were lower and trait impressions more favorable, with attenuation over time. Item-level analyses indicated sizable immediate reductions for "Disconnected" (-24%) and "Cowardly" (-16%), and smaller but significant decreases for "Immoral" and "Irresponsible" (-12% each). Conclusions: Brief survivor-narrative videos can shift public attitudes toward SLSs and maintain part of that change over 1 month. As a low-cost, scalable complement to postvention, brief video contact offers a practical lever to improve the social climate surrounding SLSs. Deployed widely and reinforced over time, it can move communities from blame to empathy, strengthen everyday support, and advance survivors' recovery.

Indexed as

BereavementSocial StigmaSuicideSurvivorsAdolescentAdultFemaleHumansMaleMiddle AgedVideo RecordingYoung Adultcontact-based video interventionpostventionpublic stigmarandomized controlled trialsuicide bereavement

Identifiers

PMID42483150
PMCPMC13385198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.